Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4246-4260
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Profiles | n | |
Compound | ||
1 | Patients with active disease (MIBDI A/B/C) and a history of hospitalization during the preceding 12 mo | 94 |
2 | Patients with significantly active disease (MIBDI A/B/C) treated with immunomodulators and biologic agents | 52 |
3 | Patients in remission while treated with immunomodulators and/or biologic agents | 26 |
4 | Patients in remission treated only with mesalamine or receiving no treatment | 90 |
5 | Patients aged 21-65 yr with any active disease (MIBDI A/B/C/D) | 341 |
6 | Patients with any active disease (MIBDI A/B/C/D) and a previous surgery for IBD | 92 |
7 | Patients older than age 50 yr, diagnosed during the preceding 12 mo | 8 |
8 | Patient younger than age 21 yr, diagnosed during the preceding 12 mo | 21 |
Simple | ||
9 | Patients diagnosed during the preceding 12 mo | 92 |
10 | Patients hospitalized during the preceding 12 mo | 163 |
11 | Patients diagnosed more than 10 yr ago | 212 |
12 | Patients who had surgery during the preceding 12 mo | 39 |
13 | Patients with highly disease activity (MIBDI A/B) | 246 |
14 | Patients diagnosed at age > 50 yr | 72 |
15 | Patients who were unemployed or received disability pension during the preceding 12 mo | 45 |
- Citation: Daher S, Khoury T, Benson A, Walker JR, Hammerman O, Kedem R, Naftali T, Eliakim R, Ben-Bassat O, Bernstein CN, Israeli E. Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey. World J Gastroenterol 2019; 25(30): 4246-4260
- URL: https://www.wjgnet.com/1007-9327/full/v25/i30/4246.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i30.4246